Radiation-induced Esophagitis Market Insights, Epidemiology, and Market Forecast
DelveInsight's "Radiation-induced Esophagitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Radiation-induced Esophagitis, historical and forecasted epidemiology as well as the Radiation-induced Esophagitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Radiation-induced Esophagitis market report provides
current treatment practices, emerging drugs, Radiation-induced Esophagitis
market share of the individual therapies, current and forecasted
Radiation-induced Esophagitis market Size from 2019 to 2032 segmented by seven
major markets. The Report also covers current Radiation-induced Esophagitis
treatment practice/algorithm, market drivers, market barriers and unmet medical
needs to curate the best of the opportunities and assesses the underlying
potential of the Radiation-induced Esophagitis market.
Do you know more about Radiation-induced Esophagitis Market Size?
Radiation-induced
Esophagitis: An Overview
Radiation-induced esophagitis is frequent and
dose-limiting toxicity of thoracic radiotherapy (RT), especially when delivered
concurrently with cytotoxic chemotherapy. Radiation esophagitis is
inflammation, edema, erythema, and erosion of the mucosal surface of the
esophagus caused by radiation therapy to nearby or related structures that
cause cell damage, produce proinflammatory cytokines, and lead to the
development of free-oxygen radical species related to radiation therapy.
Explore more related information of the report- https://www.delveinsight.com/report-store/radiation-induced-esophagitis-market-forecast?utm_source=delveinsight&utm_medium=report%20promotion&utm_campaign=yash
Radiation-induced
Esophagitis Treatment Market
Radiation esophagitis is a common, dose-limiting, early
adverse effect of radiation treatment of thoracic tumors. Its incidence is
greater with higher radiation dose and concurrent chemotherapy. Early symptoms,
usually following two to three weeks of treatment, include dysphagia and
odynophagia. Topical anesthetics such as viscous lidocaine (Xylocaine), proton
pump inhibitors, and promotility agents may provide symptomatic relief. Dietary
modifications shown to reduce incidence and severity include a bland diet and avoidance
of alcohol, coffee, and acidic foods.
Radiation-induced
Esophagitis Market Insights
Radiation esophagitis is treated symptomatically. Pain is
managed with topical analgesics such as liquid morphine sulfate. Combined
solutions of equal parts viscous xylocaine, aluminum hydroxide–magnesium carbonate,
and diphenhydramine are used. Since patients with esophagitis have decreased
lower esophageal sphincter pressure, reflux is treated with proton-pump
inhibitors and dietary modifications. Sodium bicarbonate's alkalotic properties
can treat reflux and prevent Candida albicans superinfection. Strictures are
managed with endoscopic dilation.
Radiation-induced Esophagitis Market Forecast
Amifostine, an organic triphosphate, has been studied and
shown to act as a radioprotector. It is thought that this medication acts as an
antioxidant to neutralize the free-oxygen radicals produced during ionizing radiation.
A study performed to look at the effects of amifostine in patients with
advanced non-small cell lung cancer showed improvement of swallowing
dysfunction but no effect on reducing rates of esophagitis in severe cases.
Are you aware of Radiation-induced Esophagitis Market Share?
Radiation-induced
Esophagitis Market Landscape and Emerging Drugs
The emerging drugs landscape does not represent a
particularly promising picture due to the lack of later stage clinical products
which is quite evident based on the scarcity of clinical trials being conducted
for pivotal stage in 7 MM.
Radiation-induced
Esophagitis Market Outlook
The Radiation-induced Esophagitis market outlook of the
report helps to build a detailed comprehension of the historic, current, and
forecasted Radiation-induced Esophagitis market trends by analyzing the impact
of current Radiation-induced Esophagitis therapies on the market, unmet needs,
drivers and barriers, and demand for better technology.
To get know about the related details of the market report- https://www.delveinsight.com/report-store/radiation-induced-esophagitis-market-forecast?utm_source=delveinsight&utm_medium=report%20promotion&utm_campaign=yash
Radiation-induced
Esophagitis Market Report Scope
·
The report covers the descriptive overview of
Radiation-induced Esophagitis, explaining its causes, signs and symptoms,
pathophysiology, diagnosis and currently available therapies
·
Comprehensive insight has been provided into the
Radiation-induced Esophagitis epidemiology and treatment in the 7MM
·
Additionally, an all-inclusive account of both
the current and emerging therapies for Radiation-induced Esophagitis is
provided, along with the assessment of new therapies, which will have an impact
on the current treatment landscape
·
A detailed review of the Radiation-induced
Esophagitis market; historical and forecasted is included in the report,
covering drug outreach in the 7MM
·
The report provides an edge while developing
business strategies, by understanding trends shaping and driving the global
Radiation-induced Esophagitis market
Radiation-induced Esophagitis Market Insights Report Highlights
·
In the coming years, the Radiation-induced Esophagitis
market is set to change due to the rising awareness of the disease, and
incremental healthcare spending across the world; which would expand the size
of the market to enable the drug manufacturers to penetrate more into the
market
·
The companies and academics are working to
assess challenges and seek opportunities that could influence Radiation-induced
Esophagitis R&D. The therapies under development are focused on novel
approaches to treat/improve the disease condition
·
Major players are involved in developing
therapies for Radiation-induced Esophagitis. The launch of emerging therapies
will significantly impact the Radiation-induced Esophagitis market
·
A better understanding of disease pathogenesis
will also contribute to the development of novel therapeutics for
Radiation-induced Esophagitis
·
Our in-depth analysis of the pipeline assets
across different stages of development (Phase III and Phase II), different
emerging trends and comparative analysis of pipeline products with detailed
clinical profiles, key cross-competition, launch date along with product
development activities will support the clients in the decision-making process
regarding their therapeutic portfolio by identifying the overall scenario of
the research and development activities.
For any query or doubt, just contact- Radiation-induced Esophagitis Market Companies
Latest Pharma Market Research Reports 2022 By Delveinsight
Comments
Post a Comment